BullFrog AI Holdings, Inc. $BFRG

What the company doesAI summary of filing

BullFrog AI Holdings, Inc. develops artificial intelligence and machine learning platforms for drug discovery and development. The company's primary product is bfLEAP™, an AI/ML analytics platform licensed from Johns Hopkins University Applied Physics Laboratory, which analyzes preclinical and clinical data to help identify drug candidates, patient populations, and therapeutic targets. The company generates revenue through three channels: contract services providing data analysis to biopharmaceutical companies, collaborative arrangements with drug developers, and acquisition and resale of drug development rights. The company is pre-revenue from its core AI platform but has acquired drug assets in preclinical and early clinical stages; it has not conducted its own clinical trials or generated significant revenues to date. [10-K 2026-03-19]

Segments: bfLEAP™ - AI/ML analytics platform, BullFrog Data Networks™ - bioinformatics solution, bfPREP™ - data preparation platform, Drug assets (siRNA, Mebendazole formulations)